Wanda Inc., a San Francisco-based digital health startup that offering applications and Machine Learning based health informatics for remote health and patient management, has acquired by EMV Capital, a London-based early-stage venture investor. With this acquisition, Wanda will able to stimulate its growth in the North American market, in addition to enter the UK and European markets.
Ahead of this acquisition, Co-Founder and CEO of Wanda Foad Dabiri we are delighted to welcome EMV Capital’s smart venture strategy. Their expertise in B2B technology investments and network of corporate partners will support Wanda’s growth stage. Dabiri further added that we are very excited that Wanda has reached a stage where its products and technology have proven their value to our partners and clients and now it is time for the next exciting chapter in its mission. Established in 2011 from the results of eight clinical trials at the University of California Los Angeles (UCLA), Wanda is an integrated platform embedded with active Artificial Intelligence linking doctors, clinicians, patients, and care providers into a proactive care team to stop adverse events before they happen.
As part of the acquisition, Dr. Ilian Iliev Managing Director at EMV Capital stated that he is excited to welcome Wanda, an innovative digital health company into the EMV Capital family. He further said that Wanda has shown impact and strong traction in the past couple of years and we are excited to support the company’s team through its growth phase. It fits in our investment thesis of backing exciting AI-powered technology platforms that can scale rapidly through industry partnerships. As a London-based early-stage venture investor, EMV Capital’s investments in Europe, Israel, and the US cover various technologies, ranging from robotics and AI, Machine Learning, IoT, materials science, advanced engineering, power electronics, and medical devices.